KTH Structures outlines cautious forward guidance as it navigates ongoing macroeconomic headwinds in its latest quarterly earnings release GNTA GAMCO natural resources trust reports quarterly earnings maintains preferred dividend amid commodity market volatility How Acme United ACU adapts when conditions change Modest Uptick 20260505 Lockheed Martin Corporation LMT Poised for Defense Order Growth Amid Middle East Peace Talk Impasse TherapeuticsMD TXMD Climbs 196 Resistance at 218 in Focus 20260520 Cal Resource CRC Q1 2026 Earnings Why the Beat Matters Nvidia Expands CPU Ambitions for Agentic AI Data Centers A Strategic Shift Beyond GPUs Delta Air DAL Delivers Q1 2026 Beat EPS 064 vs 058 Expected Hindu Business Line Publishes Letters to the Editor for May 28 2026 Fed Minutes Reveal Potential Rate Hikes as Iran War Risks Keep Inflation Elevated T Rowe Price Group Named Among Top HighYield Stocks for Retirement Income Signos Secures 20M Funding Expands Dexcom Partnership in GLP1 Weight Loss Wave AustralianSuper Views Potential Glencore Listing on ASX as Positive Move Jeff Bezos Proposes Tax Overhaul Aimed at LowerIncome Americans THCH Q4 2025 Earnings Deep Loss Reported Amidst Limited Disclosure ARTNA Q3 2025 Earnings Slight EPS Beat Amid Steady Utility Performance SOPA Q3 2025 Earnings EPS Falls Far Below Estimates Revenue Not Disclosed STLA Q1 2026 Earnings EPS Misses Estimates as Company Navigates Transition Challenges Alpha and Omega Semiconductor Q1 2026 Earnings EPS Surpasses Estimates Stock Jumps 67 BLCO Q1 2026 Earnings EPS Surpasses Estimates by 365 Stock Declines 14 Voyager Technologies VOYG Gains 46 Momentum Tests Key Resistance Packaging Corporation of America PKG Edges Higher Tests Middle of Established Range Gabelli Global Small and Mid Cap Value Trust GGZ Advances 129 as It Tests Key Resistance Columbus Acquisition Corp Rights COLAR Drops Nearly 9 as Technical Support Levels Approach VCI Global VCIG Surges Over 64 Analyzing the Breakout Move Roth Capital Raises Target Price Target Flags Goldilocks Quarter Risks Cybin Inc HELP Q1 2026 Earnings WiderthanExpected Loss Highlights Clinical Development Costs Intellia Therapeutics NTLA Nears Key Support Amid Continued Downtrend